Literature DB >> 23912992

Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism.

William R Lagor1, Julie C Johnston, Martin Lock, Luk H Vandenberghe, Daniel J Rader.   

Abstract

Adeno-associated viral vectors have proven to be excellent gene delivery vehicles for somatic overexpression. These viral vectors can efficiently and selectively target the liver, which plays a central role in lipoprotein metabolism. Both liver-expressed as well as non-hepatic secreted proteins can be easily examined in different mouse models using this approach. The dosability of adeno-associated viral (AAV) vectors, as well as their potential for long-term expression, makes them an excellent choice for assessing gene function in vivo. This section will cover the use of AAV to study lipoprotein metabolism-including vector design, virus production and purification, and viral delivery, as well as monitoring of transgene expression and resulting phenotypic changes. Practical information is provided to assist the investigator in designing, interpreting, and troubleshooting experiments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912992     DOI: 10.1007/978-1-60327-369-5_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.

Authors:  Kelsey E Jarrett; Ciaran Lee; Marco De Giorgi; Ayrea Hurley; Baiba K Gillard; Alexandria M Doerfler; Ang Li; Henry J Pownall; Gang Bao; William R Lagor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 2.  From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease.

Authors:  Sylvia T Nurnberg; Hanrui Zhang; Nicholas J Hand; Robert C Bauer; Danish Saleheen; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

3.  In Vivo Gene Editing in Lipid and Atherosclerosis Research.

Authors:  Marco De Giorgi; Kelsey E Jarrett; Thomas Q de Aguiar Vallim; William R Lagor
Journal:  Methods Mol Biol       Date:  2022

4.  Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase.

Authors:  Marco De Giorgi; Kelsey E Jarrett; Jason C Burton; Alexandria M Doerfler; Ayrea Hurley; Ang Li; Rachel H Hsu; Mia Furgurson; Kalyani R Patel; Jun Han; Christoph H Borchers; William R Lagor
Journal:  J Lipid Res       Date:  2020-10-27       Impact factor: 5.922

5.  Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.

Authors:  Chunxia Yao; Tina Veleva; Larry Scott; Shuyi Cao; Luge Li; Gong Chen; Prince Jeyabal; Xiaolu Pan; Katherina M Alsina; Issam Abu-Taha; Shokoufeh Ghezelbash; Corey L Reynolds; Ying H Shen; Scott A LeMaire; Wilhelm Schmitz; Frank U Müller; Ali El-Armouche; N Tony Eissa; Christine Beeton; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev; Na Li
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

Review 6.  Liver-targeted gene therapy: Approaches and challenges.

Authors:  Rajagopal N Aravalli; John D Belcher; Clifford J Steer
Journal:  Liver Transpl       Date:  2015-06       Impact factor: 6.112

Review 7.  Tribbles-1: a novel regulator of hepatic lipid metabolism in humans.

Authors:  Robert C Bauer; Batuhan O Yenilmez; Daniel J Rader
Journal:  Biochem Soc Trans       Date:  2015-10       Impact factor: 5.407

8.  Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.

Authors:  Kelsey E Jarrett; Ciaran M Lee; Yi-Hsien Yeh; Rachel H Hsu; Rajat Gupta; Min Zhang; Perla J Rodriguez; Chang Seok Lee; Baiba K Gillard; Karl-Dimiter Bissig; Henry J Pownall; James F Martin; Gang Bao; William R Lagor
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

9.  AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.

Authors:  Ang Li; Mark R Tanner; Ciaran M Lee; Ayrea E Hurley; Marco De Giorgi; Kelsey E Jarrett; Timothy H Davis; Alexandria M Doerfler; Gang Bao; Christine Beeton; William R Lagor
Journal:  Mol Ther       Date:  2020-04-19       Impact factor: 11.454

10.  Targeting the Apoa1 locus for liver-directed gene therapy.

Authors:  Marco De Giorgi; Ang Li; Ayrea Hurley; Mercedes Barzi; Alexandria M Doerfler; Nikitha A Cherayil; Harrison E Smith; Jonathan D Brown; Charles Y Lin; Karl-Dimiter Bissig; Gang Bao; William R Lagor
Journal:  Mol Ther Methods Clin Dev       Date:  2021-04-24       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.